Industrial Equity Investments

Industrial Equity Investments Limited is a strategic investment vehicle and holding company for the Piramal Group, a global business conglomerate with a dominant presence in the pharmaceutical and life sciences sectors. The company serves as a primary promoter entity for Piramal Pharma Limited, which operates a leading global Contract Development and Manufacturing Organization (CDMO) and a specialized Critical Care business. Through its strategic holdings, Industrial Equity Investments oversees a diverse portfolio that includes inhalation anesthetics, injectable pain management therapies, and advanced drug delivery platforms such as antibody-drug conjugates (ADCs). The entity plays a crucial role in the financial and strategic oversight of the Piramal Group's healthcare assets, which maintain a significant manufacturing and R&D footprint across India, the United Kingdom, and North America.